Navigation Links
State of the Mangosteen Category: 2009
Date:3/6/2009

Mangosteen category-creator XanGo continues its leadership in product innovation with green skincare application

Next phase of performance research shows XanGo(R) Juice reduces inflammation in obese subjects

Statement by Robert Conlee, CEO of XanGo, LLC

LEHI, Utah, March 6 /PRNewswire/ -- XanGo, LLC, the first company to market a premium mangosteen beverage, continues to lead the superfruit movement. As a global nutrition company, XanGo now reaches 23 countries and is expanding the benefits of the popular mangosteen to new applications. With the launch of Glimpse(TM) Intuitive Skincare, XanGo revisits its category-creating status by introducing the first personal care product to feature the power of the mangosteen at its foundation to deliver the fruit's numerous nutrients through a green, toxin-free formula that protects consumer's health and the environment.

Introducing Innovative, Topical Mangosteen Experience

The development of a personal care brand using mangosteen was a natural progression in the company's growth following last year's introduction of 3SIXTY5(TM), a whole food nutrition mangosteen-based multi-vitamin. In November 2008, XanGo introduced Glimpse Intuitive Skin Care as topical nutrition that is free of harsh chemicals and featuring green chemistry technology in self-adjusting formulas.

One of the formula's driving ingredients is BioActive X(3) Complex(TM), a proprietary ingredient that incorporates an exclusive biofermentation technology that combines meticulous, time-honored techniques with advanced science from Japan to amplify the phytonutrient potency of the mangosteen. The inclusion of these three exclusive ingredients with mangosteen-infused water helps ensure optimum nutrient density in the formulas to further promote the health-giving properties of the mangosteen.

XanGo has made a public commitment
'/>"/>

SOURCE XanGo, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AHIP Statement on White House Health Care Summit
2. Change to Win Statement on White House Health Care Forum
3. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California, Regarding President Obamas Healthcare Summit
4. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
5. IPRO QIO Uses Milliman Care Guidelines(R) for Medicare Reviews in New York State
6. European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
7. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
8. AAJ Statement on Supreme Court Decision in Favor of Diana Levine
9. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
10. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
11. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2014 Recently, BambooIndustry.com, a professional company ... collection of bamboo floors . What’s more, the ... of its products at the moment. According to the ... 26 percent off. The promotion will be valid until ... http://www.bambooindustry.com ) are all made by qualified workers. A ...
(Date:10/2/2014)... BamboofloorChina.com is a distinguished bamboo product manufacturer ... appreciation from the global customers in the past few ... more excellent items. All its online workers are professional ... , The company has recently added a new ... Furthermore, the company’s marketing specialist has announced that all ...
(Date:10/2/2014)... Children with autism are more sedentary than those without ... active, a small study suggests. Researchers tested the ... autism and some without. Children with autism averaged 50 ... 70 more minutes each day sitting than those without ... on strength, but had similar body-mass index (a measurement ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... the District of Columbia now have a total of 500 ... has been infecting children since the summer, U.S. health ... have died in recent weeks, but it,s not clear what ... deaths, officials said. Health officials are also trying to ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com: Great Bamboo Floors At Discounted Rates 2Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Study finds acupuncture does not improve chronic knee pain 2
... method cuts death risk, study finds , WEDNESDAY, Aug. ... who receive early non-invasive ventilation after a breathing tube ... failure or die, a Spanish study has found. , ... of them had high levels of carbon dioxide in ...
... behind progress, study finds , THURSDAY, Aug. 13 (HealthDay ... younger people, new research shows. , And while cancer ... the United States, topping heart disease, that is because ... cancer. , "Older Americans have only experienced decreased [cancer] ...
... YORK, Aug. 13 The International Longevity Center, with support ... $20,000 grants for caregiver training programs. , , ... Initiative grants are part of the Caregiving Project for ... the Schmieding Center for Senior Health and Education. The initiative ...
... , , BALTIMORE, Aug. ... Maryland, the Black Nurses Association of Baltimore and the Greater ... Health Insurer Code of Conduct from the American Medical Association. ... portion of the state,s racial and ethnic minorities, including African ...
... , THOUSAND OAKS, Calif., Aug. 13 ... data from the submitted Biologic License Applications (BLAs) for denosumab for ... treatment of bone loss in breast and prostate cancer patients undergoing ... Administration,s (FDA) Advisory Committee for Reproductive Health Drugs (ACRHD). , ...
... RICHMOND, Va., Aug. 13 Insmed Inc. (Nasdaq: ... second quarter and six-months ended June 30, 2009. , , ... were $3.0 million, up from $2.7 million for the corresponding period ... grant revenue related to the IPLEX(TM) myotonic muscular dystrophy ("MMD") clinical ...
Cached Medicine News:Health News:Ventilation After Breathing Tube Removal May Alter Outcomes 2Health News:Cancer Deaths Declining, Especially Among Young 2Health News:Cancer Deaths Declining, Especially Among Young 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 2Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 4Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 5Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 2Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 2Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 4Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 5Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 6Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 2Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 3Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 4Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 5Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 6Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 8Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 9
(Date:10/2/2014)... Oct. 2, 2014   Softworld, Inc. announced today ... practice solely focused on the specific needs of pharmaceutical, ... Softworld has already been highly successful in the clinical ... capabilities to support the quality, regulatory, and validation space. ... a combination of the current Biometric team and the ...
(Date:10/2/2014)... 2, 2014   Mast Therapeutics, Inc. (NYSE ... Edwin L. Parsley , D.O. has joined the ... President.  Dr. Parsley has been actively engaged ... in February 2014.  He has served as Mast,s interim ... Medical Officer of Aires since April 2011.  Dr. Parsley ...
(Date:10/2/2014)... BOSTON , Oct. 1, 2014   Intarcia ... two of its four phase 3 clinical trials for ... through a matchstick-sized, subcutaneous osmotic mini-pump). The first trial, ... that tested the efficacy and safety of ITCA 650 ... study demonstrated ITCA 650 to be significantly superior to ...
Breaking Medicine Technology:Softworld, Inc. Launches Strategic Division Dedicated to Life Sciences Consulting 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5
... June 20, 2011 Boston Scientific Corporation (NYSE: ... its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 ... wide range of peripheral angioplasty procedures.  The Company plans ... and other international markets. Boston Scientific ...
... Panacea Global Inc., ("the Company") (OTCQB: PANG), a biopharmaceutical ... diagnose and monitor cancer, today announced the change of the ... On June 15, 2011, the trading symbol for the Company,s ... was changed from MLXG to PANG.  This change was made ...
Cached Medicine Technology:Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter 2Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter 3Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG 2
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
...
Designed for stab incisions...
Medicine Products: